Double-Blind Study of Miglitol in Japanese With type2 Diabetes
Phase 3
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- NCT00380822
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Brief Summary
To investigate the efficacy and safety of miglitol in Japanese patients with type 2 diabetes that is insufficiently controlled diet alone.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Type2 diabetic patient on Dietary Therapy
- Criteria for postprandial plasma glucose and HbA1c are met
Read More
Exclusion Criteria
- Type1 diabetes
- Patients treated with antidiabetic drugs or Insulin
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method